Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

5 Jan 2026 15:30

RNS Number : 6963N
GSK PLC
05 January 2026
Β 

GSK plc (the 'Company')

Transaction notification

Β 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

David Redfern

b)

Position/status

President, Corporate Development

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GSK plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

Ordinary shares of 31 ΒΌ pence each ('Ordinary Shares')

ISIN: GB00BN7SWP63

Β 

b)

Nature of the transaction

Acquisition of Ordinary Shares following the exercise of options granted on 28 November 2022 at the option price of Β£11.39 per Ordinary Share under the Company's Share Save Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Β£11.39

790

d)

Aggregated information

Β 

Β 

N/A (single transaction)

Aggregated volume Price

e)

Date of the transaction

2026-01-02

f)

Place of the transaction

Β 

London Stock Exchange (XLON)

Β 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Victoria Whyte

b)

Position/status

SVP & Company Secretary

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GSK plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

Ordinary shares of 31 ΒΌ pence each ('Ordinary Shares')

ISIN: GB00BN7SWP63

Β 

b)

Nature of the transaction

Acquisition of Ordinary Shares following the exercise of options granted on 28 November 2022 at the option price of Β£11.39 per Ordinary Share under the Company's Share Save Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Β£11.39

790

d)

Aggregated information

Β 

Β 

N/A (single transaction)

Aggregated volume Price

e)

Date of the transaction

2026-01-02

f)

Place of the transaction

Β 

London Stock Exchange (XLON)

Β 

​

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more atΒ www.gsk.com.

Β 

Registered in England & Wales:

No. 3888792

Β 

Registered Office:

79 New Oxford Street

London

WC1A 1DG

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHSSLFLIEMSELF

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS